Skip to main content
JAMA Network logoLink to JAMA Network
. 2017 Oct 9;74(10):1271. doi: 10.1001/jamaneurol.2017.3044

Error in Abstract

PMCID: PMC6325932  PMID: 29052726

In the Original Investigation titled “Neurological Complications Associated With Anti–Programmed Death 1 (PD-1) Antibodies,”1 published online September 5, 2017, there was an error in the Abstract. In the Results section of the Abstract, the sentence “Treatment with anti–PD-1 antibodies was discontinued in all patients” should have read “in 7 patients.” This article was corrected online.

Reference

  • 1.Kao JC, Liao B, Markovic SN, et al. Neurological complications associated with anti–programmed death 1 (PD-1) antibodies [published online September 5, 2017]. JAMA Neurol. doi: 10.1001/jamaneurol.2017.1912 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Neurology are provided here courtesy of American Medical Association

RESOURCES